 controlled trial long-term bronchodilator therapy cystic fibrosis effect long-term bronchodilator therapy CF patients demonstrated bronchial hyperresponsiveness methacholine challenges responsiveness patients methacholine responders nonresponders two-month double-blind crossover trial albuterol micrograms inhalation times day vs placebo responders daily PEFR measures treatment albuterol L/min placebo L/min addition important level improvement PEFR percent increase responders Methacholine nonresponders change PEFR albuterol placebo Daily symptom scores spirometry measurements biweekly visits significant changes long-term therapy inhaled albuterol lung function CF patients bronchial hyperresponsiveness methacholine challenge